Skip to main content
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1988 Sep;95(1):268–274. doi: 10.1111/j.1476-5381.1988.tb16573.x

Pre- and post-junctional actions of procaterol, a beta 2-adrenoceptor stimulant, on dog tracheal tissue.

Y Ito 1
PMCID: PMC1854133  PMID: 2905905

Abstract

1. The effects of procaterol, a beta 2-adrenoceptor agonist, on excitatory neuro-effector transmission in the dog trachea were investigated and the findings were compared to those seen with isoprenaline, with microelectrode, double sucrose gap and tension recording methods. 2. Procaterol (10(-10)-10(-9) M) and isoprenaline (10(-9) M) had no effect on the resting membrane potential or on the input resistance of the smooth muscle cells of dog trachea. However with increased concentrations (greater than 10(-8) M), these agents hyperpolarized the membrane and decreased the input resistance of the membrane. 3. Procaterol (10(-10)-10(-7) M) and isoprenaline (10(-9)-10(-7) M) dose-dependently reduced the amplitude of the twitch contractions evoked by field stimulation in the combined presence of indomethacin (10(-5) M) and guanethidine (10(-6) M). In parallel with actions on twitch contractions, procaterol (10(-10)-10(-7) M) and isoprenaline (10(-9)-10(-7) M) reduced the amplitude of the excitatory junction potentials (e.j.ps), evoked by single pulse field stimulation in the dog trachea. 4. Procaterol (10(-8) M) had no effect on the post-junctional response of smooth muscle cells to exogenous acetylcholine (ACh) (10(-7)-10(-6) M). 5. Pretreatment with ICI-118551, a beta 2-adrenoceptor blocking agent, reduced the inhibitory action of procaterol on the amplitude of twitch contractions evoked by field stimulations in the dog trachea.(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
270

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bilski A. J., Halliday S. E., Fitzgerald J. D., Wale J. L. The pharmacology of a beta 2-selective adrenoceptor antagonist (ICI 118,551). J Cardiovasc Pharmacol. 1983 May-Jun;5(3):430–437. doi: 10.1097/00005344-198305000-00013. [DOI] [PubMed] [Google Scholar]
  2. Carswell H., Nahorski S. R. Beta-adrenoceptor heterogeneity in guinea-pig airways: comparison of functional and receptor labelling studies. Br J Pharmacol. 1983 Aug;79(4):965–971. doi: 10.1111/j.1476-5381.1983.tb10542.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Danser A. H., van den Ende R., Lorenz R. R., Flavahan N. A., Vanhoutte P. M. Prejunctional beta 1-adrenoceptors inhibit cholinergic transmission in canine bronchi. J Appl Physiol (1985) 1987 Feb;62(2):785–790. doi: 10.1152/jappl.1987.62.2.785. [DOI] [PubMed] [Google Scholar]
  4. Delhaye M., Taton G., Camus J. C., Chatelain P., Robberecht P., Waelbroeck M., Christophe J. Effects of full and partial beta-adrenergic agonists and antagonists on human lung adenylate cyclase. Biochem Pharmacol. 1983 Jun 15;32(12):1831–1835. doi: 10.1016/0006-2952(83)90046-1. [DOI] [PubMed] [Google Scholar]
  5. Fujiwara T., Sumimoto K., Itoh T., Suzuki H., Kuriyama H. Relaxing actions of procaterol, a beta 2-adrenoceptor stimulant, on smooth muscle cells of the dog trachea. Br J Pharmacol. 1988 Jan;93(1):199–209. doi: 10.1111/j.1476-5381.1988.tb11422.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Himori N., Taira N. Assessment of the selectivity of OPC-2009, a new beta2-adrenoceptor stimulatn, by the use of the blood-perfused trachea in situ and of the isolated blood-perfused papillary muscle of the dog. Br J Pharmacol. 1977 Sep;61(1):9–17. doi: 10.1111/j.1476-5381.1977.tb09734.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Inoue T., Ito Y. Characteristics of neuro-effector transmission in the smooth muscle layer of dog bronchiole and modifications by autacoids. J Physiol. 1986 Jan;370:551–565. doi: 10.1113/jphysiol.1986.sp015950. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Inoue T., Ito Y., Takeda K. Prostaglandin-induced inhibition of acetylcholine release from neuronal elements of dog tracheal tissue. J Physiol. 1984 Apr;349:553–570. doi: 10.1113/jphysiol.1984.sp015173. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Ito Y., Tajima K. Actions of indomethacin and prostaglandins on neuro-effector transmission in the dog trachea. J Physiol. 1981;319:379–392. doi: 10.1113/jphysiol.1981.sp013915. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Ito Y., Tajima K. Dual effects of catecholamines on pre- and post-junctional membranes in the dog trachea. Br J Pharmacol. 1982 Mar;75(3):433–440. doi: 10.1111/j.1476-5381.1982.tb09158.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Ito Y., Tajima K. Spontaneous activity in the trachea of dogs treated with indomethacin: an experimental model for aspirin-related asthma. Br J Pharmacol. 1981 Jun;73(2):563–571. doi: 10.1111/j.1476-5381.1981.tb10456.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Russell J. A. Noradrenergic inhibitory innervation of canine airways. J Appl Physiol Respir Environ Exerc Physiol. 1980 Jan;48(1):16–22. doi: 10.1152/jappl.1980.48.1.16. [DOI] [PubMed] [Google Scholar]
  13. Shore S., Collier B., Martin J. G. Effect of endogenous prostaglandins on acetylcholine release from dog trachealis muscle. J Appl Physiol (1985) 1987 May;62(5):1837–1844. doi: 10.1152/jappl.1987.62.5.1837. [DOI] [PubMed] [Google Scholar]
  14. Takayanagi I., Kondo N., Yamashita H., Hongo T., Takagi K. New selective beta2-adrenoreceptor stimulants 5(1-hydroxy-2-isopropylaminobutyl)- and 5-(1-hydroxy-2-ethylaminobutyl)-8-hydroxycarbostyril hydrochlorides (OPC-2009 and OPC-2030) and cyclic AMP concentration. J Pharm Pharmacol. 1977 Mar;29(3):187–189. doi: 10.1111/j.2042-7158.1977.tb11284.x. [DOI] [PubMed] [Google Scholar]
  15. Walters E. H., O'Byrne P. M., Fabbri L. M., Graf P. D., Holtzman M. J., Nadel J. A. Control of neurotransmission by prostaglandins in canine trachealis smooth muscle. J Appl Physiol Respir Environ Exerc Physiol. 1984 Jul;57(1):129–134. doi: 10.1152/jappl.1984.57.1.129. [DOI] [PubMed] [Google Scholar]
  16. Yabuuchi Y. The beta-adrenoceptor stimulant properties of OPC-2009 on guinea-pig isolated tracheal, right atrial and left atrial preparations. Br J Pharmacol. 1977 Dec;61(4):513–521. doi: 10.1111/j.1476-5381.1977.tb07543.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Yabuuchi Y., Yamashita S., Tei S. S. Pharmacological studies of OPC-2009, a newly synthesized selective beta adrenoceptor stimulant, in the broncho-motor and cardiovascular system of the anesthetized dog. J Pharmacol Exp Ther. 1977 Aug;202(2):326–336. [PubMed] [Google Scholar]
  18. Yamashita S., Takai M., Yabuuchi Y. Actions of procaterol (OPC-2009), a new beta2-adrenoceptor stimulant, on pulmonary resistance, contractions of the soleus muscle, and cardiovascular system of the anaesthetized cat. J Pharm Pharmacol. 1978 May;30(5):273–279. doi: 10.1111/j.2042-7158.1978.tb13228.x. [DOI] [PubMed] [Google Scholar]
  19. Yoshizaki S., Tanimura K., Tamada S., Yabuuchi Y., Nakagawa K. Sympathomimetic amines having a carbostyril nucleus. J Med Chem. 1976 Sep;19(9):1138–1142. doi: 10.1021/jm00231a011. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES